{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:30:12Z","timestamp":1789403412087,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11095-015-1737-8","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T21:49:51Z","timestamp":1438292991000},"page":"3756-3767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Zahra","family":"Daman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faegheh","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Nasser","family":"Ostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"issue":"6","key":"1737_CR1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1542-3565(04)00171-5","volume":"2","author":"EA Holly","year":"2004","unstructured":"Holly EA, Chaliha I, Bracci PM, Gautam M. Signs and symptoms of pancreatic cancer: a population-based case\u2013control study in the San Francisco Bay area. Clin Gastroenterol Hepatol. 2004;2(6):510\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1737_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1737_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000055290","volume":"60","author":"V Heinemann","year":"2000","unstructured":"Heinemann V. Gemcitabine: progress in the treatment of pancreatic cancer. Oncology. 2000;60(1):8\u201318.","journal-title":"Oncology"},{"issue":"1A","key":"1737_CR4","first-page":"195","volume":"27","author":"P Brusa","year":"2007","unstructured":"Brusa P, Immordino ML, Rocco F, Cattel L. Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. Anticancer Res. 2007;27(1A):195\u20139.","journal-title":"Anticancer Res"},{"issue":"2","key":"1737_CR5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2012.03.007","volume":"320","author":"SW Hung","year":"2012","unstructured":"Hung SW, Mody HR, Govindarajan R. Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. Cancer Lett. 2012;320(2):138\u201349.","journal-title":"Cancer Lett"},{"issue":"5","key":"1737_CR6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","volume":"138","author":"M Shackleton","year":"2009","unstructured":"Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138(5):822\u20139.","journal-title":"Cell"},{"issue":"1","key":"1737_CR7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2012.03.018","volume":"338","author":"Y Li","year":"2013","unstructured":"Li Y, Kong D, Ahmad A, Bao B, Sarkar FH. Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett. 2013;338(1):94\u2013100.","journal-title":"Cancer Lett"},{"issue":"12","key":"1737_CR8","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1245\/s10434-007-9540-3","volume":"14","author":"M Javle","year":"2007","unstructured":"Javle M, Gibbs J, Iwata K, Pak Y, Rutledge P, Yu J, et al. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol. 2007;14(12):3527\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"34","key":"1737_CR9","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351.","journal-title":"Oncogene"},{"issue":"4","key":"1737_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645\u201359.","journal-title":"Cell"},{"key":"1737_CR11","doi-asserted-by":"crossref","unstructured":"Naujokat C, Steinhart R. Salinomycin as a drug for targeting human cancer stem cells. BioMed Res. Int. 2012;2012.","DOI":"10.1155\/2012\/950658"},{"issue":"2","key":"1737_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.030","volume":"313","author":"G-N Zhang","year":"2011","unstructured":"Zhang G-N, Liang Y, Zhou L-J, Chen S-P, Chen G, Zhang T-P, et al. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett. 2011;313(2):137\u201344.","journal-title":"Cancer Lett"},{"issue":"8","key":"1737_CR13","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/mp5002312","volume":"11","author":"P Zhao","year":"2014","unstructured":"Zhao P, Dong S, Bhattacharyya J, Chen M. iTEP nanoparticle-delivered salinomycin displays an enhanced toxicity to cancer stem cells in orthotopic breast tumors. Mol Pharm. 2014;11(8):2703\u201312.","journal-title":"Mol Pharm"},{"issue":"1","key":"1737_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","volume":"24","author":"VP Torchilin","year":"2007","unstructured":"Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1\u201316.","journal-title":"Pharm Res"},{"issue":"2","key":"1737_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","volume":"108","author":"KS Lee","year":"2008","unstructured":"Lee KS, Chung HC, Im SA, Park YH, Kim CS, Kim S-B, et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat. 2008;108(2):241\u201350.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1737_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","volume":"72","author":"SC Kim","year":"2001","unstructured":"Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72(1):191\u2013202.","journal-title":"J Control Release"},{"issue":"1","key":"1737_CR17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2014.04.021","volume":"468","author":"Z Daman","year":"2014","unstructured":"Daman Z, Ostad S, Amini M, Gilani K. Preparation, optimization and< i> in<\/i>< i> vitro<\/i> characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles. Int J Pharm. 2014;468(1):142\u201351.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1737_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0021-9673(99)00044-8","volume":"835","author":"VG Guglielmo Dusi","year":"1999","unstructured":"Guglielmo Dusi VG. Liquid chromatography with ultraviolet detection of lasalocid, monensin, salinomycin and narasin in poultry feeds using pre-column derivatization. J Chromatogr A. 1999;835(1\u20132):243\u20136.","journal-title":"J Chromatogr A"},{"issue":"9","key":"1737_CR19","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30(9):e36. Comparative Study.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1737_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","volume":"7","author":"A Stathis","year":"2010","unstructured":"Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010;7(3):163\u201372.","journal-title":"Nat Rev Clin Oncol"},{"issue":"14","key":"1737_CR21","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009;69(14):5820\u20138.","journal-title":"Cancer Res"},{"key":"1737_CR22","unstructured":"National Centre for the Replacement Refinement & Reduction of Animals in Research. Mouse: Decision tree for blood sampling. 2014. Available from: http:\/\/www.nc3rs.org.uk\/mouse-decision-tree-blood-sampling ."},{"key":"1737_CR23","doi-asserted-by":"crossref","unstructured":"Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Cancer Nanotechnology: Springer; 2010. p. 25\u201337.","DOI":"10.1007\/978-1-60761-609-2_3"},{"issue":"3","key":"1737_CR24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2007.03.023","volume":"120","author":"C Rijcken","year":"2007","unstructured":"Rijcken C, Soga O, Hennink W, Van Nostrum C. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release. 2007;120(3):131\u201348.","journal-title":"J Control Release"},{"issue":"2","key":"1737_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2012.10.003","volume":"137","author":"J Zhang","year":"2013","unstructured":"Zhang J, Liu J. Tumor stroma as targets for cancer therapy. Pharmacol Ther. 2013;137(2):200\u201315.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1737_CR26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995;184(1):39\u201351.","journal-title":"J Immunol Methods"},{"issue":"1","key":"1737_CR27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pan.2012.11.314","volume":"13","author":"L He","year":"2013","unstructured":"He L, Wang F, Dai W-Q, Wu D, Lin C-L, Wu S-M, et al. Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines. Pancreatology. 2013;13(1):72\u20138.","journal-title":"Pancreatology"},{"issue":"1","key":"1737_CR28","first-page":"92","volume":"6","author":"M Olempska","year":"2007","unstructured":"Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int. 2007;6(1):92\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"1737_CR29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","volume":"18","author":"T-T Dong","year":"2011","unstructured":"Dong T-T, Zhou H-M, Wang L-L, Feng B, Lv B, Zheng M-H. Salinomycin selectively targets \u2018CD133+\u2019 cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol. 2011;18(6):1797\u2013804.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1737_CR30","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1073\/pnas.111614398","volume":"98","author":"J Zavadil","year":"2001","unstructured":"Zavadil J, Bitzer M, Liang D, Yang Y-C, Massimi A, Kneitz S, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-\u03b2. Proc Natl Acad Sci. 2001;98(12):6686\u201391.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1737_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franc\u00ed C, Dom\u00ednguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2(2):84\u20139.","journal-title":"Nat Cell Biol"},{"issue":"14","key":"1737_CR32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/sj.onc.1208429","volume":"24","author":"A Eger","year":"2005","unstructured":"Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene. 2005;24(14):2375\u201385.","journal-title":"Oncogene"},{"issue":"6","key":"1737_CR33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7(6):1267\u201378.","journal-title":"Mol Cell"},{"issue":"3","key":"1737_CR34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/jcs.00224","volume":"116","author":"V Bol\u00f3s","year":"2003","unstructured":"Bol\u00f3s V, Peinado H, P\u00e9rez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 2003;116(3):499\u2013511.","journal-title":"J Cell Sci"},{"issue":"3","key":"1737_CR35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10620-010-1340-0","volume":"56","author":"Z Du","year":"2011","unstructured":"Du Z, Qin R, Wei C, Wang M, Shi C, Tian R, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in \u201cstem-cell-like\u201d tumor cells. Dig Dis Sci. 2011;56(3):741\u201350.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1737_CR36","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.yexcr.2007.03.040","volume":"313","author":"J Ivaska","year":"2007","unstructured":"Ivaska J, Pallari H-M, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007;313(10):2050\u201362.","journal-title":"Exp Cell Res"},{"issue":"12","key":"1737_CR37","first-page":"5239","volume":"30","author":"Y Fuyuhiro","year":"2010","unstructured":"Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y, et al. Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res. 2010;30(12):5239\u201343.","journal-title":"Anticancer Res"},{"issue":"13","key":"1737_CR38","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1242\/jcs.113.13.2455","volume":"113","author":"B Eckes","year":"2000","unstructured":"Eckes B, Colucci-Guyon E, Smola H, Nodder S, Babinet C, Krieg T, et al. Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci. 2000;113(13):2455\u201362.","journal-title":"J Cell Sci"},{"issue":"5","key":"1737_CR39","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.juro.2009.12.092","volume":"183","author":"K-M Bae","year":"2010","unstructured":"Bae K-M, Su Z, Frye C, McClellan S, Allan RW, Andrejewski JT, et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol. 2010;183(5):2045\u201353.","journal-title":"J Urol"},{"issue":"1","key":"1737_CR40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/1471-2407-12-556","volume":"12","author":"SZ Kuo","year":"2012","unstructured":"Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan J-B, et al. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. BMC Cancer. 2012;12(1):556.","journal-title":"BMC Cancer"},{"issue":"2","key":"1737_CR41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biomaterials.2011.09.072","volume":"33","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials. 2012;33(2):679\u201391.","journal-title":"Biomaterials"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1737-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-015-1737-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-015-1737-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T18:36:36Z","timestamp":1652985396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-015-1737-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1737"],"URL":"https:\/\/doi.org\/10.1007\/s11095-015-1737-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}